John E Osborn's Net Worth
$7.16 Million
Who is John E Osborn?
John E Osborn has an estimated net worth of $7.16 Million. This is based on reported shares across multiple companies, which include Egalet Corp, CEPHALON INC, DENDREON CORP, and ONYX PHARMACEUTICALS INC.
SEC CIK
John E Osborn's CIK is 0001209721
Past Insider Trading and Trends
2006 was John E Osborn's most active year for acquiring shares with 8 total transactions. John E Osborn's most active month to acquire stocks was the month of November. 2006 was John E Osborn's most active year for disposing of shares, totalling 76 transactions. John E Osborn's most active month to dispose stocks was the month of January. 2006 saw John E Osborn paying a total of $4,506,501.25 for 154,125 shares, this is the most they've acquired in one year. In 2006 John E Osborn cashed out on 195,068 shares for a total of $7,816,302.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Egalet Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CEPHALON INC No price found
Exec VP, General Counsel & SecJohn E Osborn owns 47,680 units of Common Stock. From 2004 to 2006 John E Osborn acquired a total of 239,750 shares in CEPHALON INC at a cost of $7,197,160.00, John also disposed a total of 213,427 shares of CEPHALON INC equalling to $14,355,775.23.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.06% | -1.50K |
$73.90 | -$111,219.50 | 47.68K |
Dec 19
| |||
Form 4
| -6.31% | -3.31K |
$74.59 | -$246,892.90 | 49.19K |
Dec 17
| |||
Form 4
| +40.01% | 15K |
—
|
—
| 52.49K |
Dec 13
| |||
Form 4
| -3.86% | -1.50K |
$74.50 | -$112,122.50 | 37.49K |
Dec 3
| |||
Form 4
|
—
|
0
|
$65.63 | -$764,790.82 | 39K |
May 25
| |||
Form 4
|
—
|
0
|
$64.57 | -$369,700.00 | 39K |
May 7
| |||
Form 4
| -17.07% | -8.03K |
$70.00 | -$561,820.00 | 39K |
Dec 21
| |||
Form 4
| +35.30% | 12.27K |
$71.17 | -$194,436.44 | 47.03K |
Dec 18 - Dec 19
| |||
Form 4
| -3.45% | -1.24K |
$75.00 | -$93,150.00 | 34.76K |
Dec 1
| |||
Form 4
| -11.80% | -4.82K |
$73.87 | -$355,883.08 | 36K |
Feb 17 - Feb 21
| |||
Form 4
| -14.47% | -6.90K |
$62.68 | -$1,469,878.12 | 40.82K |
Feb 17 - Feb 21
| |||
Form 4
| +16.91% | 6.9K |
$62.10 | -$634,633.28 | 47.72K |
Feb 17
| |||
Form 4
| -1.69% | -700.00 |
—
|
—
| 40.82K |
Dec 28
| |||
Form 4
| -6.17% | -2.73K |
$56.66 | -$154,792.36 | 41.52K |
Dec 16 - Dec 19
| |||
Form 4
| +51.28% | 15K |
—
|
—
| 44.25K |
Dec 1
| |||
Form 4
| +75.55% | 12.59K |
$36.36 | -$746,554.34 | 29.25K |
Dec 15 - Dec 17
| |||
Form 4/A
| -37.51% | -10.00K |
$48.06 | -$480,600.00 | 16.66K |
Dec 13 - Dec 14
| |||
Form 4
| -39.41% | -10.84K |
$48.00 | -$520,274.28 | 16.66K |
Dec 13 - Dec 14
| |||
Form 4
| +57.14% | 10K |
$27.63 | $276,250.00 | 27.5K |
Dec 7
| |||
Form 4
| +63.34% | 6.79K |
$48.00 | -$394,272.00 | 17.5K |
Dec 17
| |||
Form 4
| -14.29% | -1.79K |
$47.52 | -$84,861.79 | 10.71K |
Dec 12
| |||
Form 4
| -23.58% | -3.86K |
$46.24 | -$178,358.82 | 12.5K |
Nov 21
| |||
Form 4
| +44.03% | 5K |
$7.88 | $39,375.00 | 16.36K |
Nov 10
| |||
Form 4
| -100.00% | -1.67K |
$48.40 | -$80,828.00 |
0
|
Sep 8
| |||
| No matching records found | |||||||||
DENDREON CORP No price found
EVP, General CounselJohn E Osborn owns 187,000 units of Common Stock. In the year 2011 John E Osborn acquired a total of 224,000 shares in DENDREON CORP.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +405.41% | 150K |
—
|
—
| 187K |
Jan 3
| |||
Form 4/A
|
∞
| 37K |
—
|
—
| 37K |
Sep 30
| |||
Form 4
|
∞
| 37K |
—
|
—
| 37K |
Aug 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONYX PHARMACEUTICALS INC No price found
SVP, Global Corporate AffairsJohn E Osborn owns 11,000 units of Common Stock. In the year 2012 John E Osborn filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 11K |
—
|
—
| 11K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||